BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6339177)

  • 1. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.
    Brook I; Yokum P
    Chemotherapy; 1983; 29(1):18-23. PubMed ID: 6339177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management.
    Brook I
    J Otolaryngol; 2001 Dec; 30(6):324-9. PubMed ID: 11771001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule.
    Brook I; Gober AE; Leyva F
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1565-8. PubMed ID: 7492105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Penicillin tolerance in group A beta-hemolytic streptococci isolated from throat cultures of children with tonsillopharyngitis].
    Ciftçi E; Doğru U; Güriz H; Aysev AD; Ince E
    Mikrobiyol Bul; 2002 Apr; 36(2):147-52. PubMed ID: 12652866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.
    Brook I
    J Fam Pract; 1994 Feb; 38(2):175-9. PubMed ID: 8308510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K; Nord CE; Olsson-Liljeqvist B
    Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.
    Brook I
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1501-8. PubMed ID: 17644191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.
    Brook I; Gilmore JD
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1452-5. PubMed ID: 8363375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.
    Brook I
    Rev Infect Dis; 1984; 6(5):601-7. PubMed ID: 6390637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Lactamase activity in human pus.
    Bryant RE; Rashad AL; Mazza JA; Hammond D
    J Infect Dis; 1980 Oct; 142(4):594-601. PubMed ID: 6969281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.
    Istre GR; Welch DF; Marks MI; Moyer N
    Antimicrob Agents Chemother; 1981 Aug; 20(2):244-6. PubMed ID: 7025754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.
    Eley A; Greenwood D
    Antimicrob Agents Chemother; 1981 Sep; 20(3):332-5. PubMed ID: 6272629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.
    Olsson B; Dornbusch K; Nord CE
    Med Microbiol Immunol; 1977 Oct; 163(3):183-94. PubMed ID: 243112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Lactamases of subspecies of Bacteroides fragilis.
    Leung T; Williams JD
    J Antimicrob Chemother; 1978 Jul; 4(B):47-54. PubMed ID: 308502
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the microbiology of group A and non-group A streptococcal tonsillitis.
    Brook I; Yocum P
    Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):243-6. PubMed ID: 3132074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin.
    Brook I; Hirokawa R
    Clin Pediatr (Phila); 1985 Jun; 24(6):331-6. PubMed ID: 3888491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.